EUVIMEDEUVIMED entdecken
Crossref

Effects of PTMs on mAb–Ligand Binding Assessed by SEC with LC-MS/MS and Correlation to Affinity and Potency Measurements

Daniel W. Woodall, David Fong, Pani Kiaei, Alexander Shcherbakov, Hong Yu Wang, Andrew B. Dykstra, Prashant N. Jethva, Joshua M. Tokuda, Nicholas J. Clark, Kelli Matthies, Qing Chen, Brian Bennett und 2 weitere

Journal of the American Society for Mass Spectrometry · 17.11.2026

DOI: 10.1021/jasms.6c00331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, online erschienen am 17.11.2026. Verfasst von Daniel W. Woodall und 13 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Amgen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic monoclonal antibodies (mAbs) accumulate a wide variety of chemical and post-translational modifications (PTMs) during production, storage, and in vivo after administration to patients. In this study, we applied size exclusion chromatography (SEC) to isolate subpopulations of different binding stoichiometries of mAb-target complexes after subjecting the mAbs to stresses relevant to manufacturing and physiological conditions. The SEC-fractionated subpopulations were analyzed by LC-MS/MS peptide mapping to identify critical PTMs that decrease ligand binding. Modifications in complementarity determining regions (CDRs) at light chain (LC) N33, heavy chain (HC) W103, and HC N104 were observed to be enriched in the SEC mAb fractions that did not bind the ligand, indicating these modifications diminish binding to the ligand. Total deamidation of N33 resulted in a moderate decrease in binding; however, when delineated into the individual D33 and isoD33 components via electron-transfer dissociation (ETD), only the isoD product was observed to significantly impact binding. Surface plasmon resonance (SPR), bead-based receptor–ligand binding, and cell-based receptor activation assays were utilized to measure the functional impact of the identified PTMs, which indicated a slight decrease in binding capacity and potency for the stressed mAbs, mirroring the trend observed by the SEC and LC-MS methods. The combination of the SEC assay and the traditional binding and potency assays provides a more complete view of the site-specific and modification-specific attributes in the context of their functional impact on decreased mAb–ligand binding and overall potency.

Förderung

  • Amgen

Zitieren

APA

Woodall, D. W., Fong, D., Kiaei, P., Shcherbakov, A., Wang, H. Y., Dykstra, A. B., Jethva, P. N., Tokuda, J. M., Clark, N. J., Matthies, K., Chen, Q., Bennett, B., Phillips, J. E., & Bondarenko, P. V. (2026). Effects of PTMs on mAb–Ligand Binding Assessed by SEC with LC-MS/MS and Correlation to Affinity and Potency Measurements. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.6c00331

Vancouver

Woodall DW, Fong D, Kiaei P, Shcherbakov A, Wang HY, Dykstra AB, et al. Effects of PTMs on mAb–Ligand Binding Assessed by SEC with LC-MS/MS and Correlation to Affinity and Potency Measurements. Journal of the American Society for Mass Spectrometry. 2026. doi:10.1021/jasms.6c00331

BibTeX
@article{Woodall2026,
  author = {Woodall, Daniel W. and Fong, David and Kiaei, Pani and Shcherbakov, Alexander and Wang, Hong Yu and Dykstra, Andrew B. and Jethva, Prashant N. and Tokuda, Joshua M. and Clark, Nicholas J. and Matthies, Kelli and Chen, Qing and Bennett, Brian and Phillips, Jonathan E. and Bondarenko, Pavel V.},
  title = {Effects of PTMs on mAb–Ligand Binding Assessed by SEC with LC-MS/MS and Correlation to Affinity and Potency Measurements},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2026},
  doi = {10.1021/jasms.6c00331}
}
Kostenlos starten →